784 related articles for article (PubMed ID: 31190408)
1. Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta-analysis, and decision analysis.
Djulbegovic M; Lee AI; Chen K
J Eval Clin Pract; 2020 Feb; 26(1):7-17. PubMed ID: 31190408
[TBL] [Abstract][Full Text] [Related]
2. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
Robertson L; Yeoh SE; Ramli A
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic therapy for secondary prevention of unprovoked venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials.
Li D; Liu Y; Song Y; Wen A
Ann Med; 2022 Dec; 54(1):253-261. PubMed ID: 35023788
[TBL] [Abstract][Full Text] [Related]
4. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
5. Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis.
Vasanthamohan L; Boonyawat K; Chai-Adisaksopha C; Crowther M
J Thromb Haemost; 2018 Jul; 16(7):1288-1295. PubMed ID: 29772108
[TBL] [Abstract][Full Text] [Related]
6. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of direct oral anticoagulants compared to warfarin for extended treatment of venous thromboembolism -a systematic review and meta-analysis.
Sindet-Pedersen C; Pallisgaard JL; Olesen JB; Gislason GH; Arevalo LC
Thromb Res; 2015 Oct; 136(4):732-8. PubMed ID: 26277682
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
Rollins BM; Silva MA; Donovan JL; Kanaan AO
Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and safety of oral anticoagulants for the treatment of venous thromboembolism in the patients with different renal functions: a systematic review, pairwise and network meta-analysis.
Su X; Yan B; Wang L; Cheng H; Chen Y
BMJ Open; 2022 Feb; 12(2):e048619. PubMed ID: 35190410
[TBL] [Abstract][Full Text] [Related]
10. Extended DOAC therapy in patients with VTE and potential risk of recurrence: A systematic review and meta-analysis.
Ebraheem M; Alzahrani I; Crowther M; Rochwerg B; Almakadi M
J Thromb Haemost; 2020 Sep; 18(9):2308-2317. PubMed ID: 32510840
[TBL] [Abstract][Full Text] [Related]
11. Direct oral anticoagulants versus standard anticoagulation in children treated for acute venous thromboembolism.
Chen J; Bi G; Wu F; Qin X
Pediatr Res; 2023 May; 93(6):1491-1498. PubMed ID: 36071237
[TBL] [Abstract][Full Text] [Related]
12. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis.
Elsebaie MAT; van Es N; Langston A; Büller HR; Gaddh M
J Thromb Haemost; 2019 Apr; 17(4):645-656. PubMed ID: 30690830
[TBL] [Abstract][Full Text] [Related]
13. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B
Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
Cohen AT; Hamilton M; Bird A; Mitchell SA; Li S; Horblyuk R; Batson S
PLoS One; 2016; 11(8):e0160064. PubMed ID: 27487187
[TBL] [Abstract][Full Text] [Related]
15. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.
Kakkos SK; Kirkilesis GI; Tsolakis IA
Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):565-75. PubMed ID: 24951377
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Thavorn K; Hutton B; Le Gal G; Fergusson DA; Rodger MA;
Ann Intern Med; 2021 Oct; 174(10):1420-1429. PubMed ID: 34516270
[TBL] [Abstract][Full Text] [Related]
17. Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis.
Mai V; Bertoletti L; Cucherat M; Jardel S; Grange C; Provencher S; Lega JC
PLoS One; 2019; 14(4):e0214134. PubMed ID: 30933993
[TBL] [Abstract][Full Text] [Related]
18. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
Gómez-Outes A; Lecumberri R; Suárez-Gea ML; Terleira-Fernández AI; Monreal M; Vargas-Castrillón E
J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423
[TBL] [Abstract][Full Text] [Related]
19. Editor's Choice - Severe Bleeding Risks of Direct Oral Anticoagulants in the Prevention and Treatment of Venous Thromboembolism: A Network Meta-Analysis of Randomised Controlled Trials.
Chen J; Lv M; Wu S; Jiang S; Xu W; Qian J; Chen M; Fang Z; Zeng Z; Zhang J
Eur J Vasc Endovasc Surg; 2022 Mar; 63(3):465-474. PubMed ID: 34973879
[TBL] [Abstract][Full Text] [Related]
20. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
Kirkilesis GI; Kakkos SK; Tsolakis IA
Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
